Evidence lost to treatment of critically-ill patients?

Minerva Anestesiologica

Volumn 75, Issue 12, 2009, Pages 715-729

  Schultz, M J ^a,b   Spronk, P E ^a,b,c   Afessa, B ^d   Gajic, O ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HERMES Critical Care Group   (Netherlands)

^c GELRE HOSPITALS   (Netherlands)

^d MAYO CLINIC   (United States)

Author keywords

Evidence based medicine; Fluid therapy; Health plan implementation; Shock, septic

Indexed keywords

ACTIVATED PROTEIN C; FLUDROCORTISONE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INSULIN; METHYLPREDNISOLONE; PLACEBO;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; ARTIFICIAL VENTILATION; BLEEDING; BLOOD GLUCOSE MONITORING; BRAIN HEMORRHAGE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFECT; EVIDENCE BASED PRACTICE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEMODYNAMIC MONITORING; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; INSULIN TREATMENT; INTENSIVE CARE; MORTALITY; NONHUMAN; PATIENT IDENTIFICATION; PATIENT SELECTION; REVIEW; SEPSIS; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL; THERAPY DELAY; TIDAL VOLUME; TREATMENT OUTCOME;

CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 74049121382     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA 1992;268:2420-5.
2. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al.Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
3. Grasselli G, Gattinoni L, Kavanagh B, Latini R, Laupacis A, Lemaire F et al. Feasibility, limits and problems of clinical studies in Intensive Care Unit. Minerva Anestesiol 2007;73:595-601.
4. Tobin MJ. Counterpoint: evidence-based medicine lacks a sound scientific base. Chest 2008;133:1071-4; discussion 1074-1077.
5. Grol R. Personal paper. Beliefs and evidence in changing clinical practice. BMJ 1997;315:418-21.
6. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30.
7. Cook DJ, Montori VM, McMullin JP, Finfer SR, Rocker GM. Improving patients' safety locally: changing clinician behaviour. Lancet 2004;363:1224-30.
8. Castro R, Regueira T, Aguirre ML, Llanos OP, Bruhn A, Bugedo G et al. An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock. Minerva Anestesiol 2008;74:223-31.
9. Rubenfeld GD, Cooper C, Carter G, Thompson BT, Hudson LD. Barriers to providing lung-protective ventilation to patients with acute lung injury. Crit Care Med 2004;32:1289-93.
10. Schultz MJ, Levi M. Prescription of rh-APC differs substantially among western European countries. Intensive Care Med 2006;32:630-1.
11. Schultz MJ, Royakkers AA, Levi M, Moeniralam HS, Spronk PE. Intensive Insulin Therapy in Intensive Care: An Example of the Struggle to Implement Evidence-Based Medicine. PLoS Med 2006;3:e456.
12. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347-54.
13. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondejar E et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998;158:1831-8.
14. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respirato-ry distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 1998;33:355-61.
15. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P, Jr., Wiener CM et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999;27:1492-8.
16. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. N Engl J Med 2000;342:1301-8.
17. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
18. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.
19. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-65.
20. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.
21. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ et al.Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-63.
22. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988;94:1176-86.
23. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717-22.
24. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995;333:1025-32.
25. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
26. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006;26:551-7.
27. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
28. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353:1332-41.
29. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL et al.Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007;369:836-43.
30. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
31. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
32. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008;36:3190-7.
33. De La Rosa GDC, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008;12:R120.
34. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
35. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738-48.
36. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
37. Hickling KG, Henderson SJ, Jackson R: Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990;16:372-7.
38. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MAD et al. Corticosteroid for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
39. Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
40. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiological doses of hydrocortisone. Crit Care Med 1998;26:645-50.
41. Bollaert PE: Stress doses of glucocorticoids in catecholamine dependency: a new therapy for a new syndrome? Intensive Care Med 2000;26:3-5.
42. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind single-center study. Crit Care Med 1999;27:723-32.
43. Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock (abstract). Crit Care Med 1999;27:A33.
44. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
45. Finfer S, Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS et al. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 2008;34:1935-47.
46. Bagshaw SM, Egi M, George C, Bellomo R. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009;37:463-70.
47. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-9.
48. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-66.
49. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-7.
50. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002;30:1686-92.
51. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009;94:410-5.
52. Schultz MJ, Spronk PE, van Braam Houckgeest F. Glucontrol, no control, or out of control? Intensive Care Med 2009. [Epub ahead of print]
53. Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008;299:2294-303.
54. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
55. Wolthuis EK, Korevaar JC, Spronk P, Kuiper MA, Dzoljic M, Vroom MB et al. Feedback and education improve physician compliance in use of lung-protective mechanical ventilation. Intensive Care Med 2005;31:540-6.
56. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R et al. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-70.
57. Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002;166:1510-4.
58. Cheng IW, Eisner MD, Thompson BT, Ware LB, Matthay MA. Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med 2005;33:63-70; discussion 239-240.
59. Kahn JM, Andersson L, Karir V, Polissar NL, Neff MJ, Rubenfeld GD. Low tidal volume ventilation does not increase sedation use in patients with acute lung injury. Crit Care Med 2005;33:766-71.
60. Wolthuis EK, Veelo DP, Choi G, Determann RM, Korevaar JC, Spronk PE et al.Mechanical ventilation with lower tidal volumes does not influence the prescription of opioids or sedatives. Crit Care 2007;11:R77.
61. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 2006;34:2714-8.
62. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007;117:910-8.
63. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002;347:993-1000.
64. Davies A, Ridley S, Hutton J, Chinn C, Barber B, Angus DC. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Anaesthesia 2005;60:155-62.
65. van Beest PA, Hofstra JJ, Schultz MJ, Boerma EC, Spronk PE, Kuiper MA. The incidence of low venous oxygen saturation on admission to the intensive care unit: a multi-center observational study in The Netherlands. Crit Care 2008;12:R33.
66. Ospina-Tascon GA, Buchele GL, Vincent JL. Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 2008;36:1311-22.
67. Herasevich V, Yilmaz M, Khan H, Chute C, Gajic O. Rule base systemfor identification of patients with specific critical care syndromes: The"Sniffer" for acute lung injury. J Am Med Informatics 2007;11:972.
68. Rana R, Afessa B, Keegan MT, Whalen FX, Jr., Nuttall GA, Evenson LK et al. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Crit Care Med 2006;34:1892-7.
69. Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelly PT et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996;335:1864-9.
70. Yilmaz M, Keegan MT, Iscimen R, Afessa B, Buck CF, Hubmayr RD et al. Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007;35:1660-6; quiz 1667.
71. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006;34:1025-32.